US Patent Issued to Regeneron Pharmaceuticals on May 6 for "Dimerizing agent regulated immunoreceptor complexes" (Washington Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,560, issued on May 6, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Dimerizing agent regulated immunoreceptor complexes" was invented by Jordan Jarjour (Seattle) and Wai-Hang Leung (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides improved compositions for adoptive T cell therapies targeting CD33 for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith. The present disclosure also relates to adoptive T cell therapies targeting CD33 and another target antige...